文献速递冠心病

心肌梗死血运重建策略:系统综述与网络荟萃分析

Percutaneous Coronary Revascularization Strategies After Myocardial Infarction: A Systematic Review and Network Meta-Analysis.
PubMed 文献 · J Am Coll Cardiol · 2024-01-01

完全血运重建显著降低全因死亡(RR: 0.85; 95% CI: 0.74-0.99; P=0.04)及心血管死亡、心肌梗死、主要不良心脏事件和重复血运重建,即刻完全血运重建在所有终点上排序优于分期策略,但需头对头试验验证。

要点

  • 完全血运重建较罪犯血管血运重建降低全因死亡(RR: 0.85;95% CI: 0.74-0.99;P=0.04)。
  • 心血管死亡、心肌梗死、主要不良心脏事件和重复血运重建亦显著减少。
  • 即刻完全血运重建在所有终点上排序优于分期完全血运重建。

核心结论

  • 心肌梗死后完全血运重建可降低全因死亡、心血管死亡、心肌梗死、主要不良心脏事件和重复血运重建。
  • 即刻完全血运重建可能有益,但尚需头对头试验验证。

研究设计与样本

  • 主要比较完全血运重建与罪犯血管血运重建,并评估完全血运重建的时机和方法,预设主要终点为全因死亡。

主要发现

  • 与罪犯血管血运重建相比,完全血运重建降低任何心肌梗死患者的全因死亡(RR: 0.85; 95% CI: 0.74-0.99; P = 0.04)。
  • 完全血运重建还显著降低心血管死亡、心肌梗死、主要不良心脏事件和重复血运重建。
  • 在ST段抬高型心肌梗死患者中,完全血运重建的全因死亡点估计为RR: 0.91(95% CI: 0.78-1.05; P = 0.18)。
  • 支架血栓形成、大出血和急性肾损伤的发生率相似。
  • 即刻完全血运重建在所有终点上排序高于分期完全血运重建。

关键数值与推荐

  • 全因死亡:完全血运重建 vs 罪犯血管血运重建,RR: 0.85(95% CI: 0.74-0.99; P = 0.04)。
  • ST段抬高型心肌梗死患者全因死亡:RR: 0.91(95% CI: 0.78-1.05; P = 0.18)。
  • 主要终点为全因死亡,结果以相对风险(RR)及95% CI表示。

临床怎么用

  • 对于心肌梗死合并多支冠状动脉疾病患者,可考虑完全血运重建以改善全因死亡等结局。
  • 即刻完全血运重建在排序上可能优于分期策略,但需结合个体情况并等待头对头试验证据。

局限性

  • 即刻完全血运重建的获益需额外头对头试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Complete revascularization with percutaneous coronary intervention improves outcomes compared with culprit revascularization following myocardial infarction (MI) with multivessel coronary artery disease. An all-cause mortality reduction has never been demonstrated. Debate also remains regarding the optimal timing of complete revascularization (immediate or staged), and method of evaluation of nonculprit lesions (physiology or angiography). OBJECTIVES: This study aims to perform an updated systematic review with frequentist and Bayesian network meta-analyses including the totality of randomized data investigating revascularization strategies in patients presenting with MI and multivessel coronary artery disease. METHODS: The primary comparison tested complete vs culprit revascularization. Timing and methods of achieving complete revascularization were assessed. The prespecified primary outcome was all-cause mortality. Outcomes were expressed as relative risk (RR) (95% CI). RESULTS: Twenty-four eligible trials randomized 16,371 patients (weighted mean follow-up: 26.4 months). Compared with culprit revascularization, complete revascularization reduced all-cause mortality in patients with any MI (RR: 0.85; 95% CI: 0.74-0.99; P = 0.04). Cardiovascular mortality, MI, major adverse cardiac events and repeat revascularization were also significantly reduced. In patients presenting with ST-segment elevation myocardial infarction, the point estimate for all-cause mortality with complete revascularization was RR: 0.91 (95% CI: 0.78-1.05; P = 0.18). Rates of stent thrombosis, major bleeding, and acute kidney injury were similar. Immediate complete revascularization ranked higher than staged complete revascularization for all endpoints. CONCLUSIONS: Complete revascularization following MI reduces all-cause mortality, cardiovascular mortality, MI, major adverse cardiac events, and repeat revascularization. There may be benefits to immediate complete revascularization, but additional head-to-head trials are needed.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Reddy, Howard, Jamil, et al. Percutaneous Coronary Revascularization Strategies After Myocardial Infarction: A Systematic Review and Network Meta-Analysis. J Am Coll Cardiol. 2024. PMID: 38986670. doi:10.1016/j.jacc.2024.04.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。